心血管・腎臓・代謝症候群と新発症心血管疾患における性差
Lin Liu1, An Ping Cai2, Kevin Chun Hei Wu1
1Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China.
Metabolism: clinical and experimental
|February 21, 2026
まとめ
男性は,より高度な心血管腎代謝症候群 (CKM) ステージと冠動脈疾患 (CHD) リスクが高く,女性はステージ3の内ではより多くの亜臨床性心不全 (HF) を示しています. これは,性別のCKM評価の必要性を強調しています.
科学分野:
- 心臓病学 心臓病学
- ネフロロジーはネフロロジーを用います.
- メタボリック・ヘルス (代謝の健康)
背景:
- 心血管・腎臓・代謝 (CKM) 症候群は,代謝リスク因子,慢性腎臓病 (CKD) と心血管機能障害を関連付けています.
- CKM症候群は,全般的な心血管疾患 (CVD) リスクに大きく貢献しています.
- 性別の違いを理解することは,パーソナライズされた心血管疾患予防戦略にとって極めて重要です.
研究 の 目的:
- CKM症候群の流行,構成要素,およびアウトカムにおける性別の違いを評価する.
- 性別とCKMの段階に基づいて,個別化された心血管疾患予防戦略を策定する.
- CKM症候群の段階と,性別に分類された心血管疾患との関連を分析する.
主な方法:
- 多民族性動脈硬化症研究 (MESA) からCVDが確立されていない6563人の参加者の分析.
- アメリカ心臓協会の基準によって定義されたCKMのステージ.
- 性別別別別の罹患率,コンポーネント分布,および冠動脈疾患 (CHD),心不全 (HF),脳卒中,および死亡率の発生率とFine-Grayサブディストリビューションハザード比率 (SHR) を用いての発生率の評価.
主要な成果:
- 男性は,進行したCKM第3段階 (42.4%対女性36.4%) のより高い罹患率を示した.
- ステージ3では,男性にはサブクリニック性動脈硬化CVD (70.5%) が多く,女性にはサブクリニック性HF (70.1%) が多くありました.
- 男性は,女性と比較して,CHDの発生率 (1000人年当たり20.9対8.9),HF (7.2対4.5),脳卒中の発生率 (6.7対6.3) が高かった.
結論:
- 男性は,高度なCKMの進行率が高く,CHDの負担が大きい.
- 女性では,CKM第3段階内で,明確なサブクリニカルHFフェノタイプを示しています.
- 性別特異的な,ステージベースのCKM評価は,早期のリスク層分化と,個別化された心血管疾患予防のために推奨されます.
関連する概念動画
01:30Coronary Artery Disease I: Introduction
1.3K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
969
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
969
01:24Chronic Kidney Disease II: Clinical Manifestations
758
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
758
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
631
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
631
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
641
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
641
01:23Assessment of the Cardiovascular System I: Subjective Data
942
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
942